RMD 1.29% $27.55 resmed inc

RMD - A possible profit clue

  1. 406 Posts.
    Respironics ( RESP - NASDAQ ) has just reported the last Q results . Part of RESPIRONICS biz is actually the second leg in the DUOPOLY of RMD/RESP in the APNEA sleep disorder market . Key drivers for the Company's domestic revenue performance include a year-over-year increase of 15 percent in domestic sleep therapy products. Let's hope RMD did the same . First call consensus expected increase for RMD is 12% in EPS growth .It is expected to report EPS USc 28 for the Q and USD 1.06 for the FY , Duff
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$27.55
Change
-0.360(1.29%)
Mkt cap ! $43.78B
Open High Low Value Volume
$27.48 $27.57 $27.37 $37.40M 1.357M

Buyers (Bids)

No. Vol. Price($)
7 226 $27.55
 

Sellers (Offers)

Price($) Vol. No.
$27.56 215 3
View Market Depth
Last trade - 11.10am 19/05/2022 (20 minute delay) ?
(live)
Last
$27.62
  Change
-0.360 ( 0.90 %)
Open High Low Volume
$27.43 $27.63 $27.37 24316
Last updated 11.28am 19/05/2022 (live) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.